Burning Rock Biotech Stock News

Burning Rock Biotech (NASDAQ:BNR) reported its Q3 earnings results on Tuesday, November 16, 2021 at 08:00 AM. Here's what investors need to know about the announcement.

GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will hold its annual general meeting (AGM) on December 28, 2021 at 10:00 a.m. (local time) at the Companys Shanghai office at 5/F, Building 1, No. 138 Xinjunhuan Road, Minhang District, Shanghai and Cleary Gottlieb Steen & Hamilton (Hong Kong) at 37/F, Hysan Place, 500 Hennessy Road, Causeway Bay, Hong Kong.

GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR , the "Company" or "Burning Rock")), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it will hold its annual general meeting ("AGM") on December 28, 2021 at 10:00 a.m. (local time) at the Company''s Shanghai office at 5/F, Building 1, No. 138 Xinjunhuan Road, Minhang District, Shanghai and Cleary Gottlieb Steen & Hamilton (Hong Kong) at 37/F, Hysan Place, 500 Hennessy Road, Causeway Bay, Hong Kong. The AGM will be held for the following proposals: To ratify the appointment of Ernst & Young Hua Ming LLP as auditor of the Company for the fiscal year ending December 31, 2021 and to authorize the directors of the Company to determine the remuneration of the auditor; To re-elect Yusheng Han, Gang Lu and Shaokun Chuai as directors of the Company; To approve, confirm and ratify the adoption of the 2021 Long-term Equity Incentive Plan and the grant of options thereunder, the vesting of which is tied to the Company''s future stock performances; and To authorize each of the directors of the Company to take any and all action that

GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2021.

GUANGZHOU, China, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company foused on the application of next generation sequenci

Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q2 2021 Results - Earnings Call Transcript

GUANGZHOU, China, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenc

GUANGZHOU, China, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a global strategic partnership with IMPACT Thera

GUANGZHOU, China, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenc

RAD, WTRH, BNR, NMR, and VNCE have been added to the Zacks Rank #5 (Strong Sell) List on June 24, 2021

BLIN, BNR, MOV, BAP and SBRA have been added to the Zacks Rank #5 (Strong Sell) List on June 11, 2021.

ADSK, BNR, NET, ELMD, and POLY have been added to the Zacks Rank #5 (Strong Sell) List on June 3, 2021

Burning Rock Biotech Limited (BNR) CEO Yusheng Han on Q1 2021 Results - Earnings Call Transcript

GUANGZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequenci